return to Bauer Lab Homepage

 

C.V. – Margaret E. Bauer, Ph.D.

 

 

 

 

EDUCATION

 

 

 

Institution

Degree

Year

Field of Study

Washington University, St. Louis, MO

A.B.

1985

Biological Sciences

University of Missouri-Columbia,

Columbia, MO

M.A.

1988

Molecular Biology

University of Wisconsin-Madison,

Madison, WI

Ph.D.

1996

Medical Microbiology

Indiana University School of Medicine, Indianapolis, IN

Postdoctoral

2000

Infectious Diseases

 

 

 

 

PROFESSIONAL EXPERIENCE

 

 

 

Department & Institution

Title

Years

Field of Study

Department of Medicine,

Indiana University School of Medicine

Assistant Scientist

2000-2004

Microbial Pathogenesis

Department of Microbiology and Immunology,

Indiana University School of Medicine

Assistant Professor

2005-present

Microbial Pathogenesis

 

 

 

Publications

 

 

1.

Bauer, M. and G. P. Smith.  1988.  Filamentous phage morphogenetic signal sequence and orientation of DNA in the virion and gene-V protein complex.  Virology 167: 166-175

2.

HŠse, C. C., M. E. Bauer, and R. A. Finkelstein.  1994.  Genetic characterization of mannose-sensitive hemagglutinin (MSHA)-negative mutants of Vibrio cholerae derived by Tn5 mutagenesis.  Gene 150: 17-25.

3.

Welch, R. A., M. E. Bauer, A. D. Kent, J. A. Leeds, M. Moayeri, L. B. Regassa, and D. L. Swenson.  1995.  Battling against host phagocytes: the wherefore of the RTX family of toxins?  Infectious Agents and Disease 4: 254-272.

4.

Bauer, M. E. and R. A. Welch.  1996.  Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7.  Infect. Immun. 64: 167-175.

5.

Bauer, M. E. and R. A. Welch.  1996.  Association of RTX toxins with erythrocytes.   Infect. Immun. 64: 4665-4672.

6.

Bauer, M. E. and R. A. Welch.  1997.  Pleiotropic effects of a mutation in rfaC on Escherichia coli hemolysin.  Infect. Immun. 65: 2218-2224.

7.

Hiltke, T. J., M. E. Bauer, J. Klesney-Tait, E. J. Hansen, R. S. Munson, Jr., and S. M. Spinola.  1999.  Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants.  Microb. Pathog. 26: 93-102.

8.

Bauer, M. E. and S. M. Spinola.  1999.  Binding of Haemophilus ducreyi to extracellular matrix proteins.  Infect. Immun.  67: 2649-2652.

9.

Al-Tawfiq, J. A., M. E. Bauer, K. R. Fortney, B. P. Katz, A. F. Hood, M. Ketterer, M. A. Apicella, and S. M. Spinola.  2000.  A pilus-deficient mutant of Haemophilus ducreyi is virulent in the human model of experimental infection.  J. Infect. Dis. 181: 1176-1179.

10.

Bauer, M. E. and S. M. Spinola.  2000.  Localization of Haemophilus ducreyi at the pustular stage of disease in the human model of infection.  Infect. Immun. 68: 2309-2314.

11.

Fortney, K. R., R. S. Young, M. E. Bauer, B. P. Katz, A. F. Hood, R. S. Munson, Jr., and S. M. Spinola.  2000.   Expression of peptidoglycan-associated lipoprotein is required for virulence in the human model of Haemophilus ducreyi infection.  Infect. Immun. 68: 6441-6448. 

12.

Bauer, M. E., M. P. Goheen, C. A. Townsend, and S. M. Spinola.  2001.  Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers.  Infect. Immun. 69:2549-2557. 

13.

Spinola, S. M., M. E. Bauer, and R. S. Munson, Jr.  2002.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).  Infect. Immun. 70:1667-1676. 

14.

Bong, C. T. H., M. E. Bauer, and S. M. Spinola.  2002.  Haemophilus ducreyi: clinical features, epidemiology and prospects for disease control.  Microbes and Infection 4:1141-1148.

15.

Spinola, S. M., C. T. H. Bong, A. Faber, K. R. Fortney, S. Bennett, C. Townsend, B. Zwickl, S. D. Billings, T. L. Humphreys, M. E. Bauer, and B. P. Katz.  2003.  Host effect on outcome in the human challenge model of Haemophilus ducreyi infection.  Infect. Immun. 71:6658-6663. 

16.

Bauer, M. E., C. A. Townsend, A. R. Ronald, and S. M. Spinola.  2006.  Localization of Haemophilus ducreyi in naturally acquired chancroid ulcers. Microb. Infect. 8:2465-2468. 

17.

Mount, K. L. B., C. A. Townsend, and M. E. Bauer.  2007.  Haemophilus ducreyi is resistant to human antimicrobial peptides.  Antimicrob. Agents Chemother. 51:3391-3393. 

18.

Bauer, M. E., K. R. Fortney, A. Harrison, D. M. Janowicz, R. S. Munson, Jr., and S. M. Spinola.  2007.  Identification of Haemophilus ducreyi genes expressed during human infection.  Microbiol. 154:1152-1160. 

19.

Bauer, M. E. C. A. Townsend, K. R. Fortney, R. Doster, B. P. Katz, S. M. Spinola, and D. M. Janowicz.  2008.  A fibrinogen-binding lipoprotein contributes to virulence of Haemophilus ducreyi in humans.  J. Infect. Dis. 199:684-692.

 

20.

Janowicz, D. M., W. Li, and M. E. Bauer.  2010.  Host-pathogen Interplay of Haemophilus ducreyi.  Curr. Op. Infect. Dis. 23:64-69. 

21.

Mount, K. L. B., C. A. Townsend, S. D. Rinker, X. Gu, K. R. Fortney, B. W. Zwickl, D. M. Janowicz, S. M. Spinola, B. P. Katz, and M. E. Bauer.  2010.  Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in humans.  Infect. Immun. 78:1176-1184.